[Clinical and coagulation physiological studies on a protease from Aspergillus ochraceus (preliminary report)].
D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D001230:Aspergillus / Q000201:enzymology*; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D004562:Electrocardiography; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007122:Immunoelectrophoresis; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D010388:Pelvis / Q000098:blood supply; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D012161:Retinal Artery; D013919:Thromboangiitis Obliterans / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy; D013925:Thromboplastin; D014581:Urticaria / Q000209:etiology
D005340:Fibrinogen; D013925:Thromboplastin; D010447:Peptide Hydrolases
Klinische und gerinnungsphysiologische Untersuchungen mit einer Protease aus Aspergillus ochraceus (Vorläufige Mitteilung)